Compare Novavax Inc (NVAX) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Veritone Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: Novavax Inc is far larger — about 13.3× Veritone Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | VERI | |
|---|---|---|
Market Cap | $1.30B | $97.60M |
Sector | Health | Technology |
52-Week High | $11.19 | $8.39 |
52-Week Low | $6.22 | $1.02 |
Enterprise Value | $800.50M | $129.63M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
